ImmunoGen announced that Anna Berkenblit, MD, Senior Vice President and Chief Medical Officer, is stepping down from her position with the company to take a well-deserved professional hiatus prior to pursuing new opportunities outside of ImmunoGen. Dr. Berkenblit will continue with the company through the end of August to support the transition of her responsibilities. Michael Vasconcelles, MD, Executive Vice President, Research, Development, and Medical Affairs, will assume the role of Chief Medical Officer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IMGN: